Trial Profile
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2023
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary) ; Metoclopramide (Primary)
- Indications Hyperemesis gravidarum
- Focus Therapeutic Use
- 07 Oct 2020 Status changed from active, no longer recruiting to completed.
- 22 Oct 2019 Planned End Date changed from 1 Sep 2019 to 1 Nov 2019.
- 22 Oct 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Oct 2019.